echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Keji Pharmaceutical's US CGMP production plant completed the first clinical batch production of CAR-T products

    Keji Pharmaceutical's US CGMP production plant completed the first clinical batch production of CAR-T products

    • Last Update: 2022-09-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    SHANGHAI, Sept.


    Exterior view of Keji Pharmaceutical's CGMP production plant

    The RTP GMP production facility, with a total construction area of ​​approximately 3,300 square meters, will provide Keji Pharmaceuticals with additional capacity to produce autologous CAR-T cell products for 700 patients per year to support clinical research and early commercial use in North America and Europe


    "The completion of the first CAR-T product for patients in the US RTP GMP manufacturing plant is a major milestone for Keji


    The internal environment of Keji Pharmaceutical's CGMP production plant

    In addition to several ongoing clinical studies in China, Keji Pharmaceutical has two ongoing IND trials approved by the US FDA and Health Canada, including CT053 for the treatment of relapsed/refractory multiple myeloma Pivotal Phase 2 clinical trial and Phase 1b clinical trial of CT041 in advanced gastric and pancreatic cancer


    Source: Keji Pharmaceutical Holdings Co.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.